Linked Life Data

17600658

Source:http://linkedlifedata.com/resource/pubmed/id/17600658

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-7-31
pubmed:abstractText
Our prior study showed that resveratrol could suppress infarct volume and exert neuroprotective effect on rats subjected to focal cerebral ischemia (FCI) injury. Recently, it has been reported in some literature that resveratrol protects the spinal cord, kidney, and heart from ischemia-reperfusion injury through upregulation of nitric oxide (NO). Therefore, this study was designed to investigate the role of nitric oxide on the neuroprotective mechanisms of resveratrol on rats after FCI injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase, http://linkedlifedata.com/resource/pubmed/chemical/Malondialdehyde, http://linkedlifedata.com/resource/pubmed/chemical/N(G)-iminoethylornithine, http://linkedlifedata.com/resource/pubmed/chemical/NG-Nitroarginine Methyl Ester, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Ornithine, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Stilbenes, http://linkedlifedata.com/resource/pubmed/chemical/resveratrol
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0741-5214
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
346-53
pubmed:meshHeading
pubmed-meshheading:17600658-Animals, pubmed-meshheading:17600658-Brain, pubmed-meshheading:17600658-Brain Ischemia, pubmed-meshheading:17600658-Carotid Arteries, pubmed-meshheading:17600658-Disease Models, Animal, pubmed-meshheading:17600658-Dose-Response Relationship, Drug, pubmed-meshheading:17600658-Enzyme Inhibitors, pubmed-meshheading:17600658-Infarction, Middle Cerebral Artery, pubmed-meshheading:17600658-L-Lactate Dehydrogenase, pubmed-meshheading:17600658-Ligation, pubmed-meshheading:17600658-Male, pubmed-meshheading:17600658-Malondialdehyde, pubmed-meshheading:17600658-Middle Cerebral Artery, pubmed-meshheading:17600658-NG-Nitroarginine Methyl Ester, pubmed-meshheading:17600658-Neuroprotective Agents, pubmed-meshheading:17600658-Nitric Oxide, pubmed-meshheading:17600658-Nitric Oxide Synthase, pubmed-meshheading:17600658-Ornithine, pubmed-meshheading:17600658-RNA, Messenger, pubmed-meshheading:17600658-Rats, pubmed-meshheading:17600658-Rats, Long-Evans, pubmed-meshheading:17600658-Stilbenes, pubmed-meshheading:17600658-Up-Regulation
pubmed:year
2007
pubmed:articleTitle
Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
pubmed:affiliation
Department of Anesthesiology, College of Medicine, Buddhist Tzu-Chi University and Hospital, Taipei, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't